Purpuromycin, an antibiotic isolated from the culture broth of Actinoplanes ianthinogenes, which is very active against Gram-positive bacteria and fungi, inhibits protein synthesis in both prokaryotic and eukaryotic cell-free systems. The ID50 was 9/tM with the endogenous mRNA-directed rabbit reticulocyte lysate, 17 ,uM with a poly(U)-directed system from Escherichia coli and 69 JuM with a poly(U)-directed system from Artemia salina cysts. Of the three steps of elongation, purpuromycin does not affect the peptidyltransferase reaction, inhibits the elongation factor 1 (EF-1) dependent binding of phenylalanyl-tRNA and stimulates the GTP-dependent binding of EF-2. When protein synthesis is stopped by the addition of purpuromycin, the nascent peptide chains are found in the puromycin-reactive P site. The results suggest that the mechanism of action of purpuromycin is similar to that of fusidic acid. Both antibiotics would seem to produce a stable guanine nucleotide-ribosome-EF-2 complex which allows one round of translocation but prevents, because of a common or overlapping ribosomal binding site for the two elongation factors, the subsequent EF-1-dependent binding of aminoacyl-tRNA.
INTRODUCTION
Purpuromycin (C26H18O13; molecular mass 538.4 Da) is an antibiotic isolated from the culture broth of Actinoplanes ianthinogenes. The antibiotic molecule contains a naphthazarin and an isocoumarin moiety. Its complete structure has been determined and is reported in Fig. 1 . It is very active against Gram-positive bacteria [minimal inhibitor concn. (MIC) 5-100 ng/ml] and fungi (MIC 50-1000 ng/ml), and has variable activity against Gramnegative bacteria (MIC 0.05-128,ug/ml) . Little information is however available on its mechanism of action at the molecular level.
The present paper describes the effect of purpuromycin on cell-free protein-synthesizing systems of prokaryotic and eukaryotic origin.
MATERIALS AND METHODS
Purpuromycin was supplied by the Lepetit Research Center, Gerenzano, Italy. The bright purple crystals were dissolved in dimethyl sulphoxide at 1 mg/ml, and appropriate dilutions were made in water. Hultin & Naislund (1978) .
Ribosomes and the postribosomal enzymic fractions were prepared from Escherichia coli as described by Wilhelm & Haselkorn (1971) and from Artemia salina cysts by the method of Sierra et al. (1974) . Rabbit reticulocyte lysate was prepared as described by Allen & Schweet (1962) . EF-1 and EF-2 were obtained from rat liver 'pH 5 supernatant' and resolved as described by Montanaro et al. (1973) . Protein synthesis assays were performed using the following methods: that of Hosokawa et al. (1966) for poly(U)-directed polyphenylalanine synthesis by E. coli ribosomes; that of Sargiacomo et al. (1983) for endogenous mRNA-directed protein synthesis by the rabbit reticulocyte lysate; and that of Barbieri et al. (1980) for poly(U)-directed synthesis of polyphenylalanine by A. salina ribosomes. Hot-acid-insoluble radioactivity was collected as described by Montanaro et al. (1978) . EF-1 -dependent phenylalanyl-tRNA binding was carried out essentially as described by Sperti et al. (1976) , with NAD+ and diphtheria toxin fragment A present in the preincubation mixture of ribosomes in order to Abbreviations used: MIC, minimal inhibitor concentration; EF-1, elongation factor 1; EF-2, elongation factor 2; EF-G, elongation factor G; A site, aminoacyl-tRNA site; P site, peptidyl-tRNA site; ID50, concentration of inhibitor causing 500o inhibition of protein synthesis.
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Vol. 259 inactivate possible traces of contaminating EF-2. The preparation of ['4C]ADP-ribosyl-EF-2 and its binding to ribosomes was essentially as described by Montanaro et al. (1975) . The reactivity of nascent peptides with [3H]puromycin during protein synthesis was measured following the method of Sperti et al. (1976) using a rabbit reticulocyte lysate system to which haemin was added to inhibit the haemin-controlled repressor (Pelham & Jackson, 1976) . All experimental details are in the legends to the Figures and the Table. 100 -RESULTS AND DISCUSSION Fig. 2 shows that purpuromycin inhibits protein synthesis in both prokaryotic and eukaryotic systems. The ID50 was 9 4uM with the rabbit reticulocyte lysate, 17 4uM with the poly(U)-directed system from E. coli, and 69 ,UM with that from A. salina embryos. The E. coli and A. salina systems contained the minimal amount of supernatant enzyme fraction which gave the maximal rate of polyphenylalanine synthesis in the presence of 2.5 pmol of ribosomes, which was the amount present in the rabbit reticulocyte system.
Since undeveloped A. salina embryos are deficient in mRNA and in one or more initiation factors (Sierra et al., 1974) Inhibition by purpuromycin of prokaryotic and eukaryotic cell-free protein-synthesizing systems The fractional activity is plotted against the log of the inhibitor concentration to calculate the ID50 values in the different systems. The ID50 is the concentration of inhibitor causing 50 / inhibition of protein synthesis. The E. coli system (@) contained, in 100 jul, 10 mM-Tris/HCl, pH 7.8, 50 mM-KCl, 10 mM-magnesium acetate, 0.03 mM-GTP, 1 mM-ATP, 6 mM-mercaptoethanol, 1 mM-dithiothreitol, 15 mM-phosphocreatine, 6,ug of creatine phosphokinase, 0.05 mm amino acids [except tyrosine, which was 0.025 mm, and phenylalanine, present as ['4C]phenylalanine (0.15 ,uCi)], 2.5 pmol of ribosomes and 75 ,/g of postribosomal enzymic fraction ('s-30'). After 10 min at 37°C, the reaction was started by the addition of 100 ,ug of poly(U initiation step, purpuromycin must, in this system, act on some elongation step. The EF-1-dependent binding of aminocyl-tRNA and the GTP-dependent binding of EF-2 were studied with A. salina ribosomes and the elongation factors from rat liver. The EF-1-dependent binding of aminoacyl-tRNA was 50 % inhibited by 94 /sM-purpuromycin (results not shown). The results reported in Table 1 confirm that the enzymic binding of phenylalanyl-tRNA was inhibited to the same extent as was protein synthesis. In contrast, the binding of ADP-ribosyl-EF-2 was increased by 4-fold.
The third step of elongation, that catalysed by ribosomal peptidyltransferase, was assayed by measuring, in the reticulocyte lysate, the reactivity of nascent peptides with [3H]puromycin. This reaction was not affected by the presence of purpuromycin (results not shown).
Since the puromycin reaction w-as not inhibited by purpuromycin, [3H]puromycin was used to titrate the number of nascent peptides located in the ribosomal peptidyl site (P site) when protein synthesis is stopped by the action of purpuromycin (Fig. 3) . The experiment was designed to clarify whether the EF-1 -catalysed step or the EF-2-catalysed step is primarily affected by purpuromycin in the complete elongation cycle.
The proportion of ribosomes bearing peptide chains in the P site, reactive with puromycin at 0°C (InoueYokosawa et al., 1974) , increases during protein synthesis . In the presence of inhibitors like ricin or diphtheria toxin , which allow a single round of translocation and not inhibit the EF-1-catalysed binding of aminoacyl-tRNA (Sperti & Montanaro, 1979) , the arrest of protein synthesis is accompanied by a decrease in the number of ribosomes bearing nascent peptides at the P site. After the single translocation, the EF-1-catalysed binding of aminoacyl-tRNA followed by peptide-bond formation occurs normally; the nascent peptides are now in the A site and, since a second translocation is prevented, they remain at this site.
As shown in Fig. 3 , this shift of the nascent peptides from the P to the A site did not occur after the addition of purpuromycin to ribosomes engaged in protein synthesis. On the contrary, the number of ribosomes bearing nascent peptides in the P site continued to increase, although at a lower rate than in the absence of purpuromycin. Thus, during the complete cycle of elongation, purpuromycin must impair the EF-I-catalysed binding of aminoacyl-tRNA; this may be a consequence of the formation of a stable guanine nucleotide-EF-2-ribosome complex (Table 1, Expt. 2) at a ribosomal site common to the two elongation factors. Translocation which is catalysed by this complex, not followed by the binding of aminoacyl-tRNA to the A site, would leave the peptide chains confined to the P site.
The mechanism by which purpuromycin inhibits protein synthesis in cell-free systems appears to be very similar to that of fusidic acid. This steroid antibiotic produced by Fusidium coccineum forms, in the presence of ribosomes, GTP and either EF-G or EF-2, a stable 'fusidic acid-GDP-ribosome-EF-G (or EF-2)' complex which prevents the subsequent EF-1-dependent binding of aminoacyl-tRNA (Vaizquez, 1979) .
